New York, United States
Jona, founded in 2022 and headquartered in the United States, is at the forefront of exploring the profound connection between the gut microbiome and human health. Under the banner of "Discover Within," the company is addressing the complex nature of microbiome science, which has shown significant insights into conditions such as autoimmune disorders, metabolic diseases, and mental health issues.
By leveraging transformative AI technology, Jona provides individuals with personalized microbiome analyses and actionable health insights. This empowers users to understand their health better and proactively manage chronic conditions.
In a promising development, Jona recently secured a $5.00M Seed Round investment on 01 November 2023 from notable investors including Meridian Street Capital, Breyer Capital, and Alumni Ventures. This funding is set to accelerate their mission to integrate microbiome science into mainstream medicine, potentially revolutionizing diagnostics and extending human longevity.
